Literature DB >> 28789776

Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994-2009.

Kelly Kamimura-Nishimura1, Tanya Froehlich2, Vilawan Chirdkiatgumchai3, Ryan Adams2, Bridget Fredstrom2, Patty Manning2.   

Abstract

PURPOSE: No prior studies have assessed change in health care provider-coded rates of Autism spectrum disorder (ASD) diagnoses over time, and few have investigated sociodemographic factors associated with having an ASD diagnosis, having behavioral conditions comorbid with ASD, or using psychotropic medications for this group.
METHODS: We used data from the 1994-2009 National (Hospital) Ambulatory Medical Care Surveys for children aged 2-18 years (n = 158,488).
RESULTS: Rates of visits with coded-ASD per 100 outpatient medical visits increased from 0.04% to 0.82% from 1994 to 2009. Factors associated with an ASD diagnosis included male gender, lack of private insurance, white race, and later study period. The most frequent comorbid behavioral diagnoses were ADHD, anxiety, disruptive behavior, and mood disorders. Older age was linked to an increased likelihood of having a comorbid behavioral diagnosis and using psychotropic medications. Geographic region was also associated with having a comorbid behavioral diagnosis, and psychotropic use was linked to have a behavioral comorbidity. Comorbidities with the highest rates of psychotropic use were ADHD, mood, and anxiety disorders.
CONCLUSIONS: Pediatric outpatient visits with an ASD diagnosis have increased dramatically from 1994 to 2009. Further study is needed to determine the reasons for the observed sociodemographic disparities in ASD diagnosis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASD diagnosis; Behavioral disorders; Psychotropics; Sociodemographic factors

Mesh:

Substances:

Year:  2017        PMID: 28789776     DOI: 10.1016/j.annepidem.2017.06.001

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  5 in total

1.  Population-Based Psychiatric Comorbidity in Children and Adolescents With Autism Spectrum Disorder: A Meta-Analysis.

Authors:  Tuba Mutluer; Herdem Aslan Genç; Aslihan Özcan Morey; Hale Yapici Eser; Beliz Ertinmaz; Merve Can; Kerim Munir
Journal:  Front Psychiatry       Date:  2022-05-23       Impact factor: 5.435

Review 2.  Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations.

Authors:  Kevin M Antshel; Natalie Russo
Journal:  Curr Psychiatry Rep       Date:  2019-03-22       Impact factor: 8.081

Review 3.  The Metal Neurotoxins: An Important Role in Current Human Neural Epidemics?

Authors:  Keith Schofield
Journal:  Int J Environ Res Public Health       Date:  2017-12-05       Impact factor: 3.390

Review 4.  Gender Trends in Psychotropic Medication Use in Autism.

Authors:  Christopher R Huber; Zachary Fanaro; Varun Soti
Journal:  Cureus       Date:  2022-06-30

5.  Latino-to-Latino: Promotores' Beliefs on Engaging Latino Participants in Autism Research.

Authors:  Karen Burkett; Kelly I Kamimura-Nishimura; Gabriela Suarez-Cano; Lorena Ferreira-Corso; Farrah Jacquez; Lisa M Vaughn
Journal:  J Racial Ethn Health Disparities       Date:  2021-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.